223 related articles for article (PubMed ID: 21896349)
1. Pneumococcal disease manifestation in children before and after vaccination: what's new?
Andrade AL; Toscano CM; Minamisava R; Costa PS; Andrade JG
Vaccine; 2011 Sep; 29 Suppl 3():C2-14. PubMed ID: 21896349
[TBL] [Abstract][Full Text] [Related]
2. [Bacteremic pneumococcal pneumonia].
Pineda Solas V; Pérez Benito A; Domingo Puiggros M; Larramona Carrera H; Segura Porta F; Fontanals Aymerich D
An Esp Pediatr; 2002 Nov; 57(5):408-13. PubMed ID: 12467543
[TBL] [Abstract][Full Text] [Related]
3. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.
Byington CL; Korgenski K; Daly J; Ampofo K; Pavia A; Mason EO
Pediatr Infect Dis J; 2006 Mar; 25(3):250-4. PubMed ID: 16511389
[TBL] [Abstract][Full Text] [Related]
4. Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases.
Pantosti A; Boccia D; D'Ambrosio F; Recchia S; Orefici G; Moro ML; ;
Microb Drug Resist; 2003; 9 Suppl 1():S61-8. PubMed ID: 14633369
[TBL] [Abstract][Full Text] [Related]
5. Serotypes of carriage and invasive isolates of Streptococcus pneumoniae in Brazilian children in the era of pneumococcal vaccines.
Laval CB; de Andrade AL; Pimenta FC; de Andrade JG; de Oliveira RM; Silva SA; de Lima EC; Fabio JL; Casagrande ST; Brandileone MC
Clin Microbiol Infect; 2006 Jan; 12(1):50-5. PubMed ID: 16460546
[TBL] [Abstract][Full Text] [Related]
6. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.
von Kries R; Siedler A; Schmitt HJ; Reinert RR
Clin Infect Dis; 2000 Aug; 31(2):482-7. PubMed ID: 10987709
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
Byington CL; Samore MH; Stoddard GJ; Barlow S; Daly J; Korgenski K; Firth S; Glover D; Jensen J; Mason EO; Shutt CK; Pavia AT
Clin Infect Dis; 2005 Jul; 41(1):21-9. PubMed ID: 15937758
[TBL] [Abstract][Full Text] [Related]
8. Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT).
Scheifele D; Halperin S; Pelletier L; Talbot J
Clin Infect Dis; 2000 Jul; 31(1):58-64. PubMed ID: 10913397
[TBL] [Abstract][Full Text] [Related]
9. [Disribution of Streptococcus pneumoniae serotypes and serogroups among patients with invasive pneumococcal diseases in the Czech Republic in 1996-2003: background data for vaccination strategy].
Motlová J
Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):3-10. PubMed ID: 15807381
[TBL] [Abstract][Full Text] [Related]
10. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.
Pai R; Moore MR; Pilishvili T; Gertz RE; Whitney CG; Beall B;
J Infect Dis; 2005 Dec; 192(11):1988-95. PubMed ID: 16267772
[TBL] [Abstract][Full Text] [Related]
11. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine.
Gonzalez BE; Hulten KG; Lamberth L; Kaplan SL; Mason EO;
Pediatr Infect Dis J; 2006 Apr; 25(4):301-5. PubMed ID: 16567980
[TBL] [Abstract][Full Text] [Related]
12. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults.
Metlay JP; Fishman NO; Joffe M; Edelstein PH
Vaccine; 2006 Jan; 24(4):468-75. PubMed ID: 16125826
[TBL] [Abstract][Full Text] [Related]
13. Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska.
Moore MR; Hyde TB; Hennessy TW; Parks DJ; Reasonover AL; Harker-Jones M; Gove J; Bruden DL; Rudolph K; Parkinson A; Butler JC; Schuchat A
J Infect Dis; 2004 Dec; 190(11):2031-8. PubMed ID: 15529269
[TBL] [Abstract][Full Text] [Related]
14. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.
Huang SS; Platt R; Rifas-Shiman SL; Pelton SI; Goldmann D; Finkelstein JA
Pediatrics; 2005 Sep; 116(3):e408-13. PubMed ID: 16140686
[TBL] [Abstract][Full Text] [Related]
15. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers.
Dagan R; Givon-Lavi N; Zamir O; Fraser D
Pediatr Infect Dis J; 2003 Jun; 22(6):532-40. PubMed ID: 12799510
[TBL] [Abstract][Full Text] [Related]
16. Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine.
Haddy RI; Perry K; Chacko CE; Helton WB; Bowling MG; Looney SW; Buck GE
Pediatr Infect Dis J; 2005 Apr; 24(4):320-3. PubMed ID: 15818291
[TBL] [Abstract][Full Text] [Related]
17. New vaccines for the prevention of pneumococcal infections.
Käyhty H; Eskola J
Emerg Infect Dis; 1996; 2(4):289-98. PubMed ID: 8969245
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological differences among pneumococcal serotypes.
Hausdorff WP; Feikin DR; Klugman KP
Lancet Infect Dis; 2005 Feb; 5(2):83-93. PubMed ID: 15680778
[TBL] [Abstract][Full Text] [Related]
19. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990--ethnic differences and opportunities for prevention.
Davidson M; Parkinson AJ; Bulkow LR; Fitzgerald MA; Peters HV; Parks DJ
J Infect Dis; 1994 Aug; 170(2):368-76. PubMed ID: 8035023
[TBL] [Abstract][Full Text] [Related]
20. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited.
Martens P; Worm SW; Lundgren B; Konradsen HB; Benfield T
BMC Infect Dis; 2004 Jun; 4():21. PubMed ID: 15228629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
